Harvard Bioscience, Inc. HBIO

7.96 (0.06) (0.75%) as of 25 Sep
Market cap
$36.5M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.95 1.48 0.96 0.99 1.62 2.39 0.98 2.04 0.98 0.34
P/FCF ratio
25.19 640.70 61.08 16.89 20.27 0.00 0.00 18.70 0.00 6.11
P/Operating CF
57.45 (122.14) 44.71 51.95 66.57 2,430.92 41.43 53.14 53.26 (309.81)
P/B ratio
1.37 1.42 1.40 1.41 2.16 3.41 1.54 3.13 1.45 2.17
Price to Tangible BV
6.41 3.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
1.03 1.57 1.40 1.38 2.01 2.73 1.35 2.32 1.69 1.05
EV/EBITDA
78.48 37.77 17.77 18.93 22.75 32.60 166.27 28.45 124.87 13.70
EV/Operating CF
19.95 114.70 58.44 19.99 22.02 257.47 133.08 18.60 110.39 13.52
EV/FCF
27.26 677.32 88.80 23.55 25.12 (3,914.78) (260.72) 21.34 (87.20) 18.69
Quick Ratio
1.75 1.59 1.16 1.15 1.24 1.17 0.91 0.77 0.35 1.12
Current Ratio
3.11 3.39 2.27 2.12 2.46 2.43 2.20 1.85 0.82 2.20
Net Debt/EBITDA
5.96 2.04 5.55 5.35 4.39 4.06 45.90 3.52 25.80 4.11
Debt/Assets
12.76% 10.74% 36.06% 32.64% 30.72% 29.77% 32.21% 26.62% 29.18% 44.80%
Debt/Equity
0.19 0.15 0.73 0.66 0.63 0.58 0.65 0.50 0.58 2.61
Asset Turnover
0.92 0.71 0.87 0.70 0.64 0.75 0.74 0.79 0.71 0.84
Operating CF/Net income
(1.25) (1.22) (0.99) (1.72) (1.19) (4.38) (0.12) (4.11) (0.12) (0.12)
Capex/Depreciation
(0.33) (0.23) (0.12) (0.15) (0.16) (0.17) (0.20) (0.25) (0.44) (0.03)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(5.75%) (1.13%) (3.57%) (5.70%) (9.86%) (0.36%) (12.23%) (4.70%) (18.19%) (147.13%)
ROA
(3.78%) (0.80%) (2.10%) (2.81%) (4.86%) (0.18%) (6.19%) (2.42%) (9.40%) (54.86%)
ROIC
(2.33%) (0.45%) 0.45% 0.19% 0.12% 1.04% (3.78%) 1.12% (4.04%) (74.07%)
Return on Tangible Assets
(12.25%) (2.32%) (7.64%) (14.19%) (22.57%) (0.73%) (30.46%) (12.90%) 261.99% (182.60%)
Average Days of Receivables
69.57 80.59 64.86 65.05 63.51 67.02 53.80 52.35 57.64 67.66
Research and Development Expense of Revenue
5.16% 7.29% 9.10% 9.22% 8.51% 9.08% 10.88% 10.48% 11.05% 10.20%
Selling, General and Administrative Expense of Revenue
39.64% 42.12% 37.94% 39.62% 42.53% 41.17% 43.71% 41.71% 46.43% 42.70%
Intangible Assets out of Total Assets
0.53 0.44 0.61 0.58 0.59 0.52 0.53 0.53 0.53 0.21
Share Based Compensation of Revenue
3.35% 4.52% 2.52% 2.61% 3.57% 3.51% 3.89% 4.45% 4.61% 2.14%
Graham Net Nets
0.10 0.17 (0.24) (0.26) (0.17) (0.06) (0.20) (0.07) (0.20) (0.61)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(4.48%) (0.61%) (3.05%) (4.00%) (4.78%) (0.20%) (8.58%) (1.40%) (13.74%) (191.04%)
Free Cash Flow Yield
3.97% 0.16% 1.64% 5.92% 4.93% (0.03%) (0.53%) 5.35% (1.98%) 16.36%
Revenue per Share
30.55 22.27 33.13 30.72 26.42 29.47 27.37 26.46 21.62 19.50
Operating CF per Share
1.57 0.30 0.79 2.13 2.41 0.31 0.28 3.31 0.33 1.52
Capex per Share
(0.42) (0.25) (0.27) (0.32) (0.36) (0.33) (0.38) (0.42) (0.75) (0.42)
Free Cash Flow per Share
1.15 0.05 0.52 1.81 2.05 (0.02) (0.11) 2.88 (0.42) 1.10
Cash per Share
1.64 1.49 2.24 2.20 2.15 1.94 1.09 1.01 0.94 1.94
Shareholders Equity per Share
21.10 23.28 22.69 21.60 19.85 20.67 17.44 17.23 14.55 3.09
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
21.10 23.28 22.69 21.60 19.85 20.67 17.44 17.23 14.55 3.09
Free Cash Flow
3.94 0.18 1.90 6.83 7.93 (0.08) (0.44) 12.23 (1.82) 4.87
Working Capital
30.87 33.49 32.34 28.26 30.65 36.27 27.88 22.50 (9.84) 26.27
Capital Expenditures
(1.44) (0.88) (0.99) (1.22) (1.40) (1.34) (1.59) (1.80) (3.26) (1.86)
Net Current Asset Value
9.90 19.08 (28.06) (29.60) (27.87) (17.36) (22.02) (15.25) (18.19) (18.11)
EV/EBIT
0.00 0.00 171.28 426.56 929.66 157.27 0.00 137.76 0.00 0.00
Capex to Sales
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.03 0.02
Net Profit Margin
(4.12%) (1.12%) (2.42%) (4.03%) (7.65%) (0.24%) (8.40%) (3.04%) (13.18%) (65.51%)
Price to Operating Income
0.00 0.00 117.81 305.92 750.07 137.67 0.00 120.72 0.00 0.00
Other line items
Depreciation/Fixed assets
1.02 1.03 1.44 1.70 2.23 2.31 2.33 1.83 1.47 11.54
Cash ROIC
1.19% (2.75%) (1.99%) 2.27% 4.04% (1.54%) (1.79%) 8.82% (3.51%) 3.34%
Accounts Receivable Turnover
5.06 4.18 6.27 5.51 5.31 6.01 5.88 6.84 6.08 5.60
Accounts Payable Turnover
7.49 7.21 9.79 8.17 7.79 9.42 9.25 7.70 7.61 8.68
Inventory Turnover
2.65 2.08 2.75 2.20 1.99 2.06 1.94 1.81 1.64 1.66
Average Days of Payables
40.31 42.10 46.64 37.58 49.47 34.97 44.81 43.90 44.38 36.38
Days of Inventory on Hand
129.82 160.83 158.99 155.29 184.43 196.47 183.76 195.36 215.51 207.26
Average Receivables
20.67 18.51 19.28 21.08 19.24 19.80 19.27 16.40 15.48 15.45
Average Payables
7.49 5.30 5.88 6.35 5.66 5.44 5.68 6.00 5.17 4.22
Average Inventory
21.15 18.40 20.97 23.57 22.16 24.92 27.01 25.58 23.98 22.03
Average Assets
113.91 108.56 138.98 166.74 160.56 159.30 153.85 141.36 132.01 103.36
Average Common Equity
74.90 76.55 81.81 82.21 79.19 80.04 77.81 72.65 68.21 38.54

Fold the line items

Columns are period end dates